{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:48:14Z","timestamp":1790358494011,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":2095,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.14283\/jpad.2018.45","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T02:10:22Z","timestamp":1614305422000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["AADvac1, an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development"],"prefix":"10.1016","volume":"6","author":[{"given":"P.","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zilkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kovacech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Skrabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ondrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fialova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kontsekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.14283\/jpad.2018.45_bib1","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule\u2013associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke\u2013Iqbal","year":"1986","journal-title":"J Biol Chem"},{"issue":"12","key":"10.14283\/jpad.2018.45_bib2","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","article-title":"Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease","volume":"85","author":"Wischik","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.14283\/jpad.2018.45_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann Neurol"},{"issue":"6","key":"10.14283\/jpad.2018.45_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.14283\/jpad.2018.45_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","article-title":"MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel\u2013based morphometry study","volume":"71","author":"Whitwell","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jpad.2018.45_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.14283\/jpad.2018.45_bib7","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awv050","article-title":"Clinicopathologic and 11C\u2013Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum","author":"Murray","year":"2015","journal-title":"Brain"},{"issue":"4","key":"10.14283\/jpad.2018.45_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer\u2013related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2018.45_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt278","article-title":"First\u2013in\u2013man tau vaccine targeting structural determinants essential for pathological tau\u2013tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.14283\/jpad.2018.45_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","article-title":"Tau\u2013based therapies in neurodegeneration: opportunities and challenges","volume":"16","author":"Li","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.14283\/jpad.2018.45_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2018.45_bib13","article-title":"Atypical","author":"Sotiropoulos","year":"2017","journal-title":"non\u2013standard functions of the microtubule associated Tau protein. Acta Neuropathol Commun"},{"key":"10.14283\/jpad.2018.45_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","author":"Violet","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.14283\/jpad.2018.45_bib15","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-140996","article-title":"N\u2013terminal Truncation of Microtubule Associated Protein Tau Dysregulates its Cellular Localization","author":"Paholikova","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2018.45_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-47","article-title":"Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways","author":"Zilka","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"12","key":"10.14283\/jpad.2018.45_bib17","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.14283\/jpad.2018.45_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.14283\/jpad.2018.45_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/156720510793611556","article-title":"Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease","volume":"7","author":"Kovacech","year":"2010","journal-title":"Curr Alzheimer Res"},{"issue":"13","key":"10.14283\/jpad.2018.45_bib20","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke\u2013Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.14283\/jpad.2018.45_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/BST20120015","article-title":"The self\u2013perpetuating tau truncation circle","volume":"40","author":"Zilka","year":"2012","journal-title":"Biochemical Society transactions"},{"issue":"4","key":"10.14283\/jpad.2018.45_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-161124","article-title":"Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis","volume":"58","author":"Skrabana","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"23","key":"10.14283\/jpad.2018.45_bib23","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.jmb.2017.09.007","article-title":"Alzheimer's Disease\u2013like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking","volume":"429","author":"Al\u2013Hilaly","year":"2017","journal-title":"Journal of molecular biology"},{"issue":"12","key":"10.14283\/jpad.2018.45_bib24","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self\u2013assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00001756-200301200-00017","article-title":"DC11: a novel monoclonal antibody revealing Alzheimer's disease\u2013specific tau epitope","volume":"14","author":"Vechterova","year":"2003","journal-title":"Neuroreport"},{"key":"10.14283\/jpad.2018.45_bib26","doi-asserted-by":"crossref","DOI":"10.1159\/000283478","article-title":"Transition of tau protein from disordered to misordered in Alzheimer's disease","author":"Kovacech","year":"2010","journal-title":"Neurodegener Dis"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","article-title":"Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament","volume":"12","author":"Novak","year":"1993","journal-title":"EMBO J"},{"issue":"6","key":"10.14283\/jpad.2018.45_bib28","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1074\/jbc.M805627200","article-title":"Conformational diversity of wild\u2013type Tau fibrils specified by templated conformation change","volume":"284","author":"Frost","year":"2009","journal-title":"J Biol Chem"},{"key":"10.14283\/jpad.2018.45_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-006-9083-3","article-title":"Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis","author":"Skrabana","year":"2006","journal-title":"Cellular and molecular neurobiology"},{"issue":"7662","key":"10.14283\/jpad.2018.45_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo\u2013EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2018.45_bib32","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of Tau Aggregates and Neurodegeneration","author":"Goedert","year":"2017","journal-title":"Annual review of neuroscience"},{"issue":"3","key":"10.14283\/jpad.2018.45_bib33","first-page":"173","article-title":"Truncated tau protein as a new marker for Alzheimer's disease","volume":"38","author":"Novak","year":"1994","journal-title":"Acta Virol"},{"issue":"7","key":"10.14283\/jpad.2018.45_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.14283\/jpad.2018.45_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","article-title":"A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity","volume":"127","author":"Ahmed","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.14283\/jpad.2018.45_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jalz.2016.01.014","article-title":"Hyperphosphorylation determines both the spread and the morphology of tau pathology","volume":"12","author":"Hu","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-009-0499-y","article-title":"Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies","volume":"118","author":"Zilka","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2018.45_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"15","key":"10.14283\/jpad.2018.45_bib39","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load","volume":"28","author":"Koson","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3233\/JAD-160347","article-title":"Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy","volume":"54","author":"Zimova","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10571-017-0491-3","article-title":"Stress\u2013Induced Alterations of Immune Profile in Animals Suffering by Tau Protein\u2013Driven Neurodegeneration","volume":"38","author":"Novak","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"10.14283\/jpad.2018.45_bib43","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.4049\/jimmunol.1100216","article-title":"Misfolded truncated protein tau induces innate immune response via MAPK pathway","volume":"187","author":"Kovac","year":"2011","journal-title":"J Immunol"},{"issue":"4","key":"10.14283\/jpad.2018.45_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-2009-1107","article-title":"Expression of a truncated human tau protein induces aqueous\u2013phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy","volume":"17","author":"Cente","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2018.45_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-009-9372-8","article-title":"Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration","author":"Filipcik","year":"2009","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"10.14283\/jpad.2018.45_bib46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1460-9568.2006.04986.x","article-title":"Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy","volume":"24","author":"Cente","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.14283\/jpad.2018.45_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt277","article-title":"Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"10.14283\/jpad.2018.45_bib48","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trci.2016.12.003","article-title":"Active Abeta immunotherapy CAD106 in Alzheimer's disease: A phase 2b study","volume":"3","author":"Vandenberghe","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","article-title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double\u2013blind, placebocontrolled, phase 1 trial","volume":"16","author":"Novak","year":"2017","journal-title":"Lancet Neurol"},{"issue":"20","key":"10.14283\/jpad.2018.45_bib51","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2174\/15680266113136660181","article-title":"Immune senescence and vaccination in the elderly","volume":"13","author":"Lang","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.14283\/jpad.2018.45_bib52","article-title":"Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods","author":"Hobart","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2018.45_bib53","article-title":"Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory","author":"Hobart","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2018.45_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2012.05.2187","article-title":"The ADAS\u2013Cog revisited: novel composite scales based on ADAS\u2013Cog to improve efficiency in MCI and early AD trials","author":"Raghavan","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.14283\/jpad.2018.45_bib55","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno\u2013Tempini","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","article-title":"Neuropathological background of phenotypical variability in frontotemporal dementia","volume":"122","author":"Josephs","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.14283\/jpad.2018.45_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamaneurol.2016.0412","article-title":"Features of Patients With Nonfluent\/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration","volume":"73","author":"Santos\u2013Santos","year":"2016","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneurol.2009.216","article-title":"Primary progressive aphasia: clinicopathological correlations","volume":"6","author":"Grossman","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"10.14283\/jpad.2018.45_bib59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.14283\/jpad.2018.45_bib60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.0000000000003688","article-title":"Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias","volume":"88","author":"Steinacker","year":"2017","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.45_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0345-3","article-title":"A language\u2013based sum score for the course and therapeutic intervention in primary progressive aphasia","author":"Semler","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2018.45_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awn234","article-title":"Development of methodology for conducting clinical trials in frontotemporal lobar degeneration","author":"Knopman","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.14283\/jpad.2018.45_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000346277","article-title":"Validation of the Amsterdam IADL Questionnaire(c), a new tool to measure instrumental activities of daily living in dementia","volume":"41","author":"Sikkes","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.14283\/jpad.2018.45_bib64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-170390","article-title":"PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)","volume":"60","author":"Rafii","year":"2017","journal-title":"J Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:52:12Z","timestamp":1736452332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724005028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2274580724005028"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2018.45","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AADvac1, an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2018.45","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}